Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Synovis Life Technologies, Inc. (“Synovis” or the “Company”) (NASDAQ: SYNO) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Baxter International, Inc. in an all-cash deal valued at about $325 million. Under the terms of the proposed transaction, Synovis stockholders will receive $28.00 in cash for each share of Synovis common stock they own. Request more information now by clicking here: www.faruqilaw.com/SYNO. Whether Synovis’s Board of Directors breached their fiduciary duties to the Company’s stockholders by failing to conduct an adequate and fair sales process prior to agreeing to this proposed transaction, whether the proposed transaction undervalues Synovis’s shares and by how much this proposed transaction undervalues the Company to the detriment of Synovis’s shareholders are the key focus of this investigation. Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm’s clients. If you own common stock in Synovis and wish to obtain additional information, please visit us at www.faruqilaw.com/SYNO or contact Juan E. Monteverde, Esq. either via e-mail at email@example.com or by telephone at (877) 247-4292 or (212) 983-9330. Attorney Advertising. (C) 2011 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case.
Synovis Life Technologies (Nasdaq:SYNO) hit a new 52-week high Tuesday as it is currently trading at $28.01, above its previous 52-week high of $28 with 31,366 shares traded as of 1:32 p.m. ET. Average volume has been 165,800 shares over the past 30 days.
Synovis Life Technologies (Nasdaq:SYNO) hit a new 52-week high Tuesday as it is currently trading at $27.98, above its previous 52-week high of $27.97 with 52,394 shares traded as of 3 p.m. ET. Average volume has been 165,800 shares over the past 30 days.
Shares of Synovis Life Technologies (Nasdaq:SYNO) were gapping up Tuesday morning with an open price 50.5% higher than Monday's closing price. The stock closed at $18.44 yesterday and opened today's trading at $27.75.